Why the study?
Does high-dose neuroleptic treatment differ in patient characteristics and effectiveness compared to regular-dose treatment in psychiatric patients?
Does high-dose neuroleptic treatment differ in patient characteristics and effectiveness compared to regular-dose treatment in psychiatric patients?
High-dose neuroleptic treatment is often prescribed to a subgroup of chronic, regressed, and violent patients despite a lack of clear evidence for its effectiveness.
Answers are grounded in this paper and cite their sources.
High-dose neuroleptics appear reserved for refractory cases; leaves open whether escalation improves outcomes in severe psychiatric illness.
OBJECTIVE: High doses of neuroleptic medication are still administered to many patients, although many studies have shown the effectiveness of low-dose strategies. The purposes of the study were to determine whether and in what ways high-dose patients differed from patients on regular dosages and whether the higher dosages were more effective. METHODS: In a case-control study at two large state hospitals, 38 high-dose patients were compared with 29 regular-dose patients. RESULTS: The high-dose patients had a persistent course of illness, with severe chronic symptoms resulting in hospitalizations of much longer duration than those of the regular-dose patients. The high-dose patients evidenced more regressed functioning and were more violent. To control these behaviors, clinicians increased neuroleptic dosages. CONCLUSIONS: The high-dose patients represented a subgroup of chronic regressed and violent patients. Clinicians prescribed high dosages and continued to use them despite a lack of clear evidence that such treatment is effective.
No takes yet. Share an insight, caveat, or question.
Kunz et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: